Mantle cell lymphoma New Drug: Pirtobrutinib in Mantle Cell Lymphoma Ulas D. Bayraktar, MD 2023-03-15
Colorectal Cancer New Drug: Adagrasib with/without Cetuximab in kRAS G12C Mutant Colorectal Cancer Ulas D. Bayraktar, MD 2023-03-15
Head and Neck Cancer New Indicaiton: DOCEtaxel as a Radiosensitizer in Head and Neck Cancer Ulas D. Bayraktar, MD 2023-03-15
Pancreatic Cancer New Indication: Sotorasib in kRAS G12C Mutant Pancreatic Cancer Ulas D. Bayraktar, MD 2023-03-15
Non-Small Cell Lung Cancer New Indication: Adjuvant Pembrolizumab for NSCLC Ulas D. Bayraktar, MD 2023-03-15
Colorectal Cancer New Protocol: Tucatinib and Trastuzumab for Metastatic Colorectal Cancer Ulas D. Bayraktar, MD 2023-03-15
Follicular Lymphoma New Drug: Mosunetuzumab for R/R Follicular Lymphoma Ulas D. Bayraktar, MD 2023-01-10
Non-Small Cell Lung Cancer New Protocol: Cemiplimab with Chemotherapy in NSCLC Ulas D. Bayraktar, MD 2023-01-10
Non-Small Cell Lung Cancer New Indication: Durvalumab with Tremelimumab in Metastatic NSCLC Ulas D. Bayraktar, MD 2023-01-10
